1-5 of 5
Silvana Perconti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells (CD30.CAR EBVSTs) Provide a Safe and Effective Off-the-Shelf Therapy for Patients with CD30-Positive Lymphoma

David H. Quach, Carlos A. Ramos, Premal D. Lulla, Sandhya Sharma, Haran R. Ganesh, Nazila Nouraee, Yolanda D. Briones, Yezan F. Hadidi, Luis Becerra-Dominguez, Sachin G. Thakkar, Birju Mehta, Silvana Perconti, Emily M. Hsieh, Huimin Zhang, Bambi J. Grilley, Malcolm K. Brenner, Helen E. Heslop, Rayne H. Rouce, Natalia Lapteva, Cliona M. Rooney
Journal: Blood
Blood (2022) 140 (Supplement 1): 412–414.
https://doi.org/10.1182/blood-2022-160244
Published: 2022
Journal Articles

Safety and Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma

David H. Quach, Carlos A. Ramos, Premal D. Lulla, Sandhya Sharma, Haran R. Ganesh, Yezan F. Hadidi, Sachin G. Thakkar, Luis Becerra-Dominguez, Birju Mehta, Silvana Perconti, Eric Anderson, Emily M. Hsieh, Olga Dakhova, Huimin Zhang, Bambi J. Grilley, Malcolm K. Brenner, Helen E. Heslop, Rayne H. Rouce, Natalia Lapteva, Cliona M. Rooney
Journal: Blood
Blood (2021) 138 (Supplement 1): 1763.
https://doi.org/10.1182/blood-2021-153421
Published: 2021
Journal Articles

Early Signals of Anti-Tumor Efficacy and Safety with Autologous CD5.CAR T-Cells in Patients with Refractory/Relapsed T-Cell Lymphoma

Rayne H. Rouce, LaQuisa C. Hill, Tyler S. Smith, Lina Yang, Blakely Boriskie, Madhuwanti Srinivasan, Huimin Zhang, Silvana Perconti, Birju Mehta, Olga Dakhova, Bambi J. Grilley, Helen E. Heslop, Malcolm K. Brenner, Maksim Mamonkin
Journal: Blood
Blood (2021) 138 (Supplement 1): 654.
https://doi.org/10.1182/blood-2021-154142
Published: 2021
Journal Articles

A Bank of CD30.CAR-Modified, Epstein-Barr Virus-Specific T Cells That Lacks Host Reactivity and Resists Graft Rejection for Patients with CD30-Positive Lymphoma

David H. Quach, PhD, Haran R. Ganesh, BS, Sachin Thakkar, PhD, Luis Becerra-Dominguez, BS, Birju Mehta, MS, Silvana Perconti, MS, Eric Anderson, BS, Emily M. Hsieh, MD, Olga Dakhova, MD, Huimin Zhang, BS, Bambi J. Grilley, RPh, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD DSc, Carlos A. Ramos, MD, Rayne H. Rouce, MD, Natalia Lapteva, PhD, Cliona M. Rooney, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16.
https://doi.org/10.1182/blood-2020-141491
Published: 2020
Journal Articles

Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies

LaQuisa C. Hill, MD, Rayne H. Rouce, MD, Tyler S. Smith, Lina Yang, PhD, Madhuwanti Srinivasan, Huimin Zhang, BS, Silvana Perconti, Birju Mehta, MS, BS, Olga Dakhova, Josalind Randall, Bambi J. Grilley, RPh, Helen E. Heslop, MD DSc, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 199.
https://doi.org/10.1182/blood-2019-129559
Published: 2019